This report presents the results of the EEIQAP 2024 for molecular detection, subtyping and characterisation of potentially zoonotic type A influenza viruses carried out by national influenza reference laboratories in the EU/EEA and Western Balkan countries and Türkiye.
The objective of this review was to investigate the efficacy, effectiveness, immunogenicity and safety of HPV vaccination in non-HIV immunocompromised individuals of any age.
This report presents the results of an ECDC survey among members of the SoHO-Net blood group on the donor assessment and deferral strategies for blood donors in the EU/EEA countries with regard to dengue virus.
ECDC is cooperating with countries in the Western Balkans and Türkiye to improve their infectious disease prevention and control systems and public health workforce in order to prepare them for their future participation in the Centre’s work.
Between 2023 and 2025, EU/EEA countries reported 82 cases caused by C. diphtheriae ST574 to ECDC. Of these, at least 25 were in individuals from vulnerable groups.
This rapid risk assessment provides an overview of a multi-country hepatitis A outbreak in the EU/EEA during early 2025, highlighting its impact on vulnerable populations and identifying two closely related virus strains across affected regions.
